Trial intelligence / Profile preview

Magnesium Sulphate in Perinatal Asphyxia

NCT00553072Phase 3Completed

Sponsor
Sher-i-Kashmir Institute of Medical Sciences
Start
Sep 2004
Primary completion
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of magnesium sulfate in perinatal asphyxia, hypoxic-ischemic encephalopathy (HIE), sponsored by Sher-i-Kashmir Institute of Medical Sciences. Started Sep 2004; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

perinatal asphyxiahypoxic-ischemic encephalopathy (HIE)

Beyond the preview

Go deeper on NCT00553072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00553072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call